ID

17186

Description

A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00152386

Link

https://clinicaltrials.gov/show/NCT00152386

Keywords

  1. 8/30/16 8/30/16 -
Uploaded on

August 30, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Rheumatoid Arthritis NCT00152386

Eligibility Rheumatoid Arthritis NCT00152386

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female, aged at least 18 years old at the screening visit.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
a clear chest x-ray within 3 months prior to baseline visit.
Description

chest x-ray

Data type

boolean

Alias
UMLS CUI [1]
C0039985
a diagnosis of adult-onset ra (of at least six months duration but not longer than 15 years prior to screening) as defined by the 1987 american college of rheumatology classification criteria.
Description

adult-onset ra

Data type

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C1853562
active ra disease at screening and baseline as defined by:
Description

Active rheumatoid arthritis

Data type

boolean

Alias
UMLS CUI [1]
C0003873
≥9 tender joints.
Description

tender joint count

Data type

boolean

Alias
UMLS CUI [1]
C0451530
≥9 swollen joints. and fulfilling 1 of the following 2 criteria:
Description

swollen joint count

Data type

boolean

Alias
UMLS CUI [1]
C0451521
≥30 mm/hour esr (westergren), or
Description

Westergren ESR

Data type

boolean

Alias
UMLS CUI [1]
C0200705
crp >15 mg/l.
Description

CRP

Data type

boolean

Alias
UMLS CUI [1]
C0201657
must have received a stable dose of mtx with or without folic acid for at least 3 months prior to baseline visit. the minimum dose is 10 mg mtx weekly.
Description

stable dose of mtx

Data type

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0205360
patient must be willing to attend for a week 52 x-ray of the hands and feet even if they are no longer receiving study treatment but have not withdrawn their informed consent.
Description

Compliance behavior

Data type

boolean

Alias
UMLS CUI [1]
C1321605
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
a diagnosis of any other inflammatory arthritis e.g., psoriatic arthritis or ankylosing spondylitis.
Description

other inflammatory arthritis

Data type

boolean

Alias
UMLS CUI [1,1]
C0003864
UMLS CUI [1,2]
C0205394
a secondary, non-inflammatory type of arthritis (e.g. oa or fibromyalgia) that in the investigator's opinion is symptomatic enough to interfere with evaluation of the effect of cdp870 on the patient's primary diagnosis of ra.
Description

non-inflammatory type of arthritis

Data type

boolean

Alias
UMLS CUI [1,1]
C0003864
UMLS CUI [1,2]
C0442743
a history of an infected joint prosthesis at any time with prosthesis still in situ.
Description

infected joint prosthesis

Data type

boolean

Alias
UMLS CUI [1]
C0410808
does not meet exclusionary concomitant medication criteria.
Description

Concomitant medication

Data type

boolean

Alias
UMLS CUI [1]
C2347852
a history of a lymphoproliferative disorder including lymphoma or signs and symptoms suggestive of lymphoproliferative disease at any time.
Description

lymphoproliferative disorder

Data type

boolean

Alias
UMLS CUI [1]
C0024314
patients at a high risk of infection in the investigator's opinion (e.g. leg ulcers, indwelling urinary catheter and persistent or recurrent chest infections).
Description

High risk of infection

Data type

boolean

Alias
UMLS CUI [1]
C0582147

Similar models

Eligibility Rheumatoid Arthritis NCT00152386

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male and female, aged at least 18 years old at the screening visit.
boolean
C0001779 (UMLS CUI [1])
chest x-ray
Item
a clear chest x-ray within 3 months prior to baseline visit.
boolean
C0039985 (UMLS CUI [1])
adult-onset ra
Item
a diagnosis of adult-onset ra (of at least six months duration but not longer than 15 years prior to screening) as defined by the 1987 american college of rheumatology classification criteria.
boolean
C0003873 (UMLS CUI [1,1])
C1853562 (UMLS CUI [1,2])
Active rheumatoid arthritis
Item
active ra disease at screening and baseline as defined by:
boolean
C0003873 (UMLS CUI [1])
tender joint count
Item
≥9 tender joints.
boolean
C0451530 (UMLS CUI [1])
swollen joint count
Item
≥9 swollen joints. and fulfilling 1 of the following 2 criteria:
boolean
C0451521 (UMLS CUI [1])
Westergren ESR
Item
≥30 mm/hour esr (westergren), or
boolean
C0200705 (UMLS CUI [1])
CRP
Item
crp >15 mg/l.
boolean
C0201657 (UMLS CUI [1])
stable dose of mtx
Item
must have received a stable dose of mtx with or without folic acid for at least 3 months prior to baseline visit. the minimum dose is 10 mg mtx weekly.
boolean
C0025677 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
Compliance behavior
Item
patient must be willing to attend for a week 52 x-ray of the hands and feet even if they are no longer receiving study treatment but have not withdrawn their informed consent.
boolean
C1321605 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
other inflammatory arthritis
Item
a diagnosis of any other inflammatory arthritis e.g., psoriatic arthritis or ankylosing spondylitis.
boolean
C0003864 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
non-inflammatory type of arthritis
Item
a secondary, non-inflammatory type of arthritis (e.g. oa or fibromyalgia) that in the investigator's opinion is symptomatic enough to interfere with evaluation of the effect of cdp870 on the patient's primary diagnosis of ra.
boolean
C0003864 (UMLS CUI [1,1])
C0442743 (UMLS CUI [1,2])
infected joint prosthesis
Item
a history of an infected joint prosthesis at any time with prosthesis still in situ.
boolean
C0410808 (UMLS CUI [1])
Concomitant medication
Item
does not meet exclusionary concomitant medication criteria.
boolean
C2347852 (UMLS CUI [1])
lymphoproliferative disorder
Item
a history of a lymphoproliferative disorder including lymphoma or signs and symptoms suggestive of lymphoproliferative disease at any time.
boolean
C0024314 (UMLS CUI [1])
High risk of infection
Item
patients at a high risk of infection in the investigator's opinion (e.g. leg ulcers, indwelling urinary catheter and persistent or recurrent chest infections).
boolean
C0582147 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial